{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T20:50:16Z","timestamp":1785790216734,"version":"3.56.0"},"reference-count":26,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"9","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,9]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>How metastatic nodal burden influences the prognosis of school-age children and adolescents (SACAs) with papillary thyroid cancer (PTC) remains unclear. We investigated the independent impact of numerical metastatic nodal burden on clinical outcomes in these patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and Methods:<\/jats:title>\n                    <jats:p>This multicenter retrospective cohort study included SACAs with PTC aged 18 years and older who had undergone total thyroidectomy and radioiodine therapy across 12 nuclear medicine departments in China. Persistent biochemical and structural diseases were evaluated. The independent role of metastatic nodes in persistent disease was evaluated using Cox proportional hazards regression.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      In total, 486 SACAs with PTC were analyzed, of whom 115 had N1a and 371 had N1b. Among SACAs with N1b PTC, a higher number of metastatic lymph nodes, analyzed as a continuous variable, was identified as an independent risk factor for persistent structural disease (HR: 1.06; 95% CI: 1.01\u20131.11). When analyzed as a categorical variable, patients in the third (16\u201322 nodes) and fourth (&gt;22 nodes) quartiles of the number of metastatic nodes exhibited an increased hazard of persistent structural disease (HR: 3.35; 95% CI: 1.13\u20139.97;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      =0.029 and HR: 5.52; 95% CI: 1.59\u201319.13;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      =0.007, respectively). ROC analysis identified a cutoff of \u226514 metastatic lymph nodes for predicting persistent structural diseases. However, for SACAs with N1a PTC, analysis of the number of metastatic nodes revealed no association with persistent disease.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>The number of metastatic nodes is a predominant factor associated with persistent disease, and incorporating quantitative assessment of metastatic nodes may improve risk stratification in SACAs with N1b PTC.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/rlu.0000000000006547","type":"journal-article","created":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T18:00:27Z","timestamp":1785348027000},"page":"791-797","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Prognostic Value of Number of Metastatic Nodes in School-Age Children and Adolescents With Papillary Thyroid Cancer"],"prefix":"10.1097","volume":"51","author":[{"given":"Liu","family":"Xiao","sequence":"first","affiliation":[{"name":"Department of Nuclear Medicine, West China Hospital of Sichuan University, Chengdu"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Chang","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, The First Affiliated Hospital of Zhengzhou University, Zhengzhou"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huijuan","family":"Feng","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, Zhujiang Hospital of Southern Medical University, Guangzhou"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaobo","family":"Yao","sequence":"additional","affiliation":[{"name":"Departments of Nuclear Medicine, The First Affiliated Hospital of USTC, University of Science and Technology of China, Hefei"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingzhi","family":"Cao","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, Affiliated Hospital of North Sichuan Medical College, Nanchong"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Menghui","family":"Yuan","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, Tangdu Hospital, Fourth Military Medical University, Xi\u2019an, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0636-9680","authenticated-orcid":false,"given":"Bin","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, West China Hospital of Sichuan University, Chengdu"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,7,6]]},"reference":[{"key":"R1-20260803","doi-asserted-by":"crossref","first-page":"1270518","DOI":"10.3389\/fendo.2023.1270518","article-title":"Global incidence and prevalence of differentiated thyroid cancer in childhood: systematic review and meta-analysis","volume":"14","author":"Moleti","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"key":"R2-20260803","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1210\/endrev\/bnaf003","article-title":"Molecular landscape and therapeutic strategies in pediatric and adolescent differentiated thyroid carcinoma","volume":"46","author":"Yang","year":"2025","journal-title":"Endocr Rev"},{"key":"R3-20260803","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1089\/thy.2018.0067","article-title":"Incidence and survival of thyroid cancer in children,pediatric and adolescent and adolescents, and young adults in Denmark: a nationwide study from 1980 to 2014","volume":"28","author":"Schmidt","year":"2018","journal-title":"Thyroid"},{"key":"R4-20260803","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1001\/jamaoto.2019.0898","article-title":"pediatric and adolescent thyroid cancer incidence and mortality trends in the United States, 1973-2013","volume":"145","author":"Qian","year":"2019","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"key":"R5-20260803","first-page":"1095","article-title":"Changing incidence and projections of thyroid cancer in mainland China, 1983-2032: evidence from Cancer Incidence in Five Continents","volume":"32","author":"Li","year":"2021","journal-title":"Cancer Causes Control"},{"key":"R6-20260803","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1016\/j.surg.2020.12.047","article-title":"Influence of body mass index at diagnosis on outcome of thyroid cancer in children andpediatric and adolescent and adolescents","volume":"169","author":"Zhang","year":"2021","journal-title":"Surgery"},{"key":"R7-20260803","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1177\/10507256251363120","article-title":"2025 American Thyroid Association Management guidelines for adult patients with differentiated thyroid cancer","volume":"35","author":"Ringel","year":"2025","journal-title":"Thyroid"},{"key":"R8-20260803","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1089\/thy.2014.0460","article-title":"Management guidelines for children with thyroid nodules and differentiated thyroid cancer","volume":"25","author":"Francis","year":"2015","journal-title":"Thyroid"},{"key":"R9-20260803","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1002\/ohn.373","article-title":"Prognostic value of tumor multifocality in pediatric and adolescent papillary thyroid carcinoma: a real-life multicentric study","volume":"169","author":"Xu","year":"2023","journal-title":"Otolaryngol Head Neck Surg"},{"key":"R10-20260803","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1097\/RLU.0000000000004758","article-title":"No association of preablation thyroglobulin antibody positivity and outcome in pediatric and adolescent patients with papillary thyroid carcinoma","volume":"48","author":"Xu","year":"2023","journal-title":"Clin Nucl Med"},{"key":"R11-20260803","doi-asserted-by":"crossref","first-page":"e4688","DOI":"10.1210\/clinem\/dgab445","article-title":"Prognostic implications of preablation stimulated Tg: a retrospective analysis of 2500 thyroid cancer patients","volume":"106","author":"Tian","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"key":"R12-20260803","doi-asserted-by":"crossref","first-page":"1970","DOI":"10.1210\/jc.2015-3960","article-title":"Pediatric and adolescent thyroid cancer: postoperative classifications and response to initial therapy as prognostic factors","volume":"101","author":"Lazar","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"R13-20260803","first-page":"793","article-title":"Initial and dynamic risk stratification of pediatric and adolescent patients with differentiated thyroid cancer","volume":"102","author":"Sung","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"key":"R14-20260803","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1089\/thy.2017.0214","article-title":"Practical initial risk stratification based on lymph node metastases in pediatric and adolescent andpediatric and adolescent and adolescent differentiated thyroid cancer","volume":"28","author":"Jeon","year":"2018","journal-title":"Thyroid"},{"key":"R15-20260803","doi-asserted-by":"crossref","first-page":"3732","DOI":"10.3390\/cancers13153732","article-title":"Differentiated thyroid cancer in children and pediatric and adolescent and adolescents: long term outcome and risk factors for persistent disease","volume":"13","author":"Sapuppo","year":"2021","journal-title":"Cancers (Basel)"},{"key":"R16-20260803","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1002\/hed.27208","article-title":"Fourteen years old as the best age cutoff to differentiate prepubertal from pubertal papillary thyroid carcinoma","volume":"45","author":"He","year":"2023","journal-title":"Head Neck"},{"key":"R17-20260803","doi-asserted-by":"crossref","first-page":"399","DOI":"10.3390\/diagnostics15040399","article-title":"Differentiated thyroid cancer long-term outcomes and risk stratification in pediatric and adolescent and pediatric and adolescent and adolescent patients: a 44-year retrospective study","volume":"15","author":"Buta","year":"2025","journal-title":"Diagnostics (Basel)"},{"key":"R18-20260803","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/j.surg.2018.09.015","article-title":"The definition of lymph node micrometastases in pathologic N1a papillary thyroid carcinoma should be revised","volume":"165","author":"Lee","year":"2019","journal-title":"Surgery"},{"key":"R19-20260803","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1089\/thy.2017.0334","article-title":"Nodal factors predictive of recurrence after thyroidectomy and neck dissection for papillary thyroid carcinoma","volume":"28","author":"Nam","year":"2018","journal-title":"Thyroid"},{"key":"R20-20260803","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.1200\/JCO.2014.59.8391","article-title":"Presence and number of lymph node metastases are associated with compromised survival for patients younger than age 45 years with papillary thyroid cancer","volume":"33","author":"Adam","year":"2015","journal-title":"J Clin Oncol"},{"key":"R21-20260803","doi-asserted-by":"crossref","first-page":"5723","DOI":"10.1210\/jc.2005-0285","article-title":"Prognostic factors for persistent or recurrent disease of papillary thyroid carcinoma with neck lymph node metastases and\/or tumor extension beyond the thyroid capsule at initial diagnosis","volume":"90","author":"Leboulleux","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"R22-20260803","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0039-6060(03)00384-2","article-title":"A novel classification system for patients with PTC: addition of the new variables of large (3 cm or greater) nodal metastases and reclassification during the follow-up period","volume":"135","author":"Sugitani","year":"2004","journal-title":"Surgery"},{"key":"R23-20260803","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1089\/thy.2012.0043","article-title":"The prognostic significance of nodal metastases from papillary thyroid carcinoma can be stratified based on the size and number of metastatic lymph nodes, as well as the presence of extranodal extension","volume":"22","author":"Randolph","year":"2012","journal-title":"Thyroid"},{"key":"R24-20260803","doi-asserted-by":"crossref","first-page":"106984","DOI":"10.1016\/j.oraloncology.2024.106984","article-title":"Prognostic implications of lymph node yield in pediatric and adolescent patients with N1b papillary thyroid cancer","volume":"158","author":"Wei","year":"2024","journal-title":"Oral Oncol"},{"key":"R25-20260803","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1007\/s12020-024-03974-2","article-title":"Prognostic significance of metastatic lymph node size and extra-nodal extension in papillary thyroid carcinoma according to the 9th edition of general rules for the description of thyroid cancer risk stratification: a single center validation study","volume":"87","author":"Yamazaki","year":"2025","journal-title":"Endocrine"},{"key":"R26-20260803","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.jpedsurg.2022.07.010","article-title":"Optimal value of lymph node ratio and metastatic lymph node size to predict risk of recurrence in pediatric and adolescent thyroid cancer with lateral neck metastasis","volume":"58","author":"Back","year":"2023","journal-title":"J Pediatr Surg"}],"container-title":["Clinical Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/RLU.0000000000006547","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T20:01:43Z","timestamp":1785787303000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/RLU.0000000000006547"}},"subtitle":["A Real-Life Multicenter Study"],"short-title":[],"issued":{"date-parts":[[2026,7,6]]},"references-count":26,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/rlu.0000000000006547","relation":{},"ISSN":["0363-9762","1536-0229"],"issn-type":[{"value":"0363-9762","type":"print"},{"value":"1536-0229","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,6]]},"assertion":[{"value":"2026-03-19","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-04-24","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}